On September 25, Guoyao Holdings (1099.HK) rose nearly 5% to HK$18.86 intraday, hitting a new high for about a month since August 26 this year. According to the HKEX equity disclosure information, on September 17, Sinopharm received an additional shareholding of 0.4004 million shares by FMR LLC at an average price of HK$16.8969 per share, involving approximately HK$6.7651 million. After the additional shareholding, its latest shareholding ratio increased from 11.98% to 12.01%. In addition, on September 20, Sinopharm received an additional shareholding of 10.5517 million shares by Lazard Asset Management LLC at an average price of HK$17.10 per share, involving approximately HK$0.18 billion. After the additional shareholding, its latest shareholding ratio increased from 7.76% to 8.55%.
港股异动丨国药控股涨近5% 股价收复近一个月失地
Hong Kong stocks anomaly: Sinopharm rose nearly 5%, and the stock price regained ground lost in nearly a month.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.